rs9610271

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000962868.1(MAPK1):​c.*655A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 152,110 control chromosomes in the GnomAD database, including 7,282 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7280 hom., cov: 32)
Exomes 𝑓: 0.31 ( 2 hom. )

Consequence

MAPK1
ENST00000962868.1 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.740

Publications

11 publications found
Variant links:
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
MAPK1 Gene-Disease associations (from GenCC):
  • Noonan syndrome 13
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.378 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000962868.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK1
ENST00000962868.1
c.*655A>G
3_prime_UTR
Exon 9 of 9ENSP00000632927.1

Frequencies

GnomAD3 genomes
AF:
0.292
AC:
44388
AN:
151940
Hom.:
7280
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.382
Gnomad AMR
AF:
0.302
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.209
Gnomad FIN
AF:
0.263
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.382
Gnomad OTH
AF:
0.345
GnomAD4 exome
AF:
0.308
AC:
16
AN:
52
Hom.:
2
Cov.:
0
AF XY:
0.222
AC XY:
8
AN XY:
36
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.326
AC:
15
AN:
46
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.563
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.292
AC:
44395
AN:
152058
Hom.:
7280
Cov.:
32
AF XY:
0.284
AC XY:
21141
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.164
AC:
6811
AN:
41486
American (AMR)
AF:
0.302
AC:
4607
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
1528
AN:
3468
East Asian (EAS)
AF:
0.100
AC:
520
AN:
5182
South Asian (SAS)
AF:
0.210
AC:
1011
AN:
4818
European-Finnish (FIN)
AF:
0.263
AC:
2782
AN:
10560
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.382
AC:
25945
AN:
67956
Other (OTH)
AF:
0.341
AC:
719
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1552
3104
4657
6209
7761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.358
Hom.:
13003
Bravo
AF:
0.290
Asia WGS
AF:
0.152
AC:
530
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.1
DANN
Benign
0.52
PhyloP100
-0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9610271; hg19: chr22-22112527; API